Hepatocellular Carcinoma

Doctors predict success in percutaneous ethanol injection for liver cancer

Published in Cancer Weekly, October 22nd, 2002

by Sonia Nichols, senior medical writer - Doctors in Japan have defined the major factors that predict outcomes in those who receive percutaneous ethanol injection (PEI) therapy for primary liver cancer.

Hepatocellular carcinoma (HCC) is a common form of primary liver cancer. HCC, associated with viral hepatitis, alcohol use and toxin exposure, can be treated with a variety of methods.

One of those methods is PEI, wherein alcohol is injected directly into the tumor to choke off cancer growth. PEI is particularly useful for treating smaller tumors. After looking at 100 patients treated with PEI for small HCCs, Hitoshi Kuriyama and colleagues,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2002-10-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry